OHSU Scientist Makes Recommendations To Improve Expert Testimony In The Courtroom

June 06, 1997

In a court of law, plaintiff and defense lawyers often present scientific experts to support their contentions. Whose scientists are correct? How do a judge and jury determine which scientific experts are credible?

Using the silicone breast implant litigation as an example, James T. Rosenbaum, M.D., professor of medicine at Oregon Health Sciences University, illustrates how scientific testimony can conflict. His policy recommendations appear in the June 6, 1997 issue of the journal Science. Rosenbaum offers suggestions to improve the reliability and independence of scientific expert testimony in the courtroom.

"Scientific bodies should not wait for the court to seek advice; as scientists we should ensure that every court has at its disposal a listing of neutral experts with specified areas of expertise and acknowledgment of potential conflicts," says Rosenbaum.

Using the breast implant litigation as an example, Rosenbaum suggests two solutions to potential conflicts: either allow the court to appoint experts to testify or empanel a group of experts to advise the court. He notes that the National Institutes of Health maintains a roster of potential scientific experts who are checked for conflicts of interests. Other resources for scientific guidance are the American Association for the Advancement of Science and the National Academy of Sciences.

"In the case of silicone implants, juries need unbiased guidance to fathom the immunology, epidemiology, biochemistry and pathogenesis of autoimmune disease," explains Rosenbaum. In August 1996, U.S. District Court Judge Robert E. Jones heard arguments on the scientific admissibility of evidence relative to alleged silicone disease. The Ninth Circuit Daubert opinion has noted, "Though we are largely untrained in science and certainly no match for any of the witnesses whose testimony we are reviewing, it is our responsibility to determine whose experts' proposed testimony amounts to 'scientific knowledge,' constitutes 'good science,' and was derived from the scientific method."

With the aid of a scientific adviser, Richard Jones, M.D., Ph.D., former chairman of biochemistry at OHSU, Judge Robert E. Jones enlisted four neutral panelists to advise on the admissibility of opinions offered by the plaintiffs' experts for lawsuits involving silicone breast implants pending in his jurisdiction.

Using the report from the panel, Judge Jones ruled that the plaintiffs' "scientific" experts could not offer opinions on causation issues. In reaching this conclusion, Judge Robert E. Jones noted that the opinions of the scientists hired by the plaintiffs were not based on tested hypotheses; their analyses of experimental studies involved an extrapolation that represented a "leap of faith"; no study had found an increase in relative risk greater than 2 for any disease; the proposed experts had relied on differential diagnosis, a process that is not reliable in establishing causation; and their opinion differed from the prevailing consensus.

"Although this opinion is having a far-reaching effect," explains Rosenbaum, "it is not binding on state courts where the vast majority of implant cases are being tried. Nor does the ruling bind other federal district courts. One other federal judge who has been assigned breast implant litigation is also seeking advice from a similar panel. In two other federal cases, courts have limited the testimony on causation by the plaintiffs' experts.

"The proceedings before Judge Robert E. Jones demonstrate the appropriate use of a scientific advisory panel. Although this approach entails some expense, the cost is trivial compared to the $50 billion at stake in the silicone breast implant litigation. Although scientific 'truth' is not immutable, the courts have recognized that scientific arguments for causation must meet definable standards and that scientists themselves, either as experts appointed by the court or as advisers to the court, are best qualified to judge science."

Rosenbaum further explains that breast implant litigation is just one example of the need for courts to seek scientific advice. "Regardless of how one feels about breast implants, the 'plea' in my article is for scientists to volunteer in an organized fashion to advise judges and juries."

Oregon Health & Science University

Related Disease Articles from Brightsurf:

CLCN6 identified as disease gene for a severe form of lysosomal neurodegenerative disease
A mutation in the CLCN6 gene is associated with a novel, particularly severe neurodegenerative disorder.

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

Potential link for Alzheimer's disease and common brain disease that mimics its symptoms
A new study by investigators from Brigham and Women's Hospital uncovered a group of closely related genes that may capture molecular links between Alzheimer's disease and Limbic-predominant Age-related TDP-43 Encephalopathy, or LATE, a recently recognized common brain disorder that can mimic Alzheimer's symptoms.

Antioxidant agent may prevent chronic kidney disease and Parkinson's disease
Researchers from Osaka University developed a novel dietary silicon-based antioxidant agent with renoprotective and neuroprotective effects.

Tools used to study human disease reveal coral disease risk factors
In a study published in Scientific Reports, a team of international researchers led by University of Hawai'i (UH) at Mānoa postdoctoral fellow Jamie Caldwell used a statistical technique typically employed in human epidemiology to determine the ecological risk factors affecting the prevalence of two coral diseases--growth anomalies, abnormalities like coral tumors, and white syndromes, infectious diseases similar to flesh eating bacteria.

Disease-aggravating mutation found in a mouse model of neonatal mitochondrial disease
The new mitochondrial DNA (mtDNA) variant drastically speeds up the disease progression in a mouse model of GRACILE syndrome.

Human longevity largest study of its kind shows early detection of disease & disease risks
Human Longevity, Inc. (HLI) announced the publication of a ground-breaking study in the journal Proceedings of the National Academy of Sciences (PNAS).

30-year study identifies need of disease-modifying therapies for maple syrup urine disease
A new study analyzes 30 years of patient data and details the clinical course of 184 individuals with genetically diverse forms of Maple Syrup Urine Disease (MSUD), which is among the most volatile and dangerous inherited metabolic disorders.

Long-dormant disease becomes most dominant foliar disease in New York onion crops
Until recently, Stemphylium leaf blight has been considered a minor foliar disease as it has not done much damage in New York since the early 1990s.

Read More: Disease News and Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.